KR101566320B1 - 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물을 포함하는 피부 재생, 진정 및 자극완화용 화장료조성물 - Google Patents
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물을 포함하는 피부 재생, 진정 및 자극완화용 화장료조성물 Download PDFInfo
- Publication number
- KR101566320B1 KR101566320B1 KR1020150121238A KR20150121238A KR101566320B1 KR 101566320 B1 KR101566320 B1 KR 101566320B1 KR 1020150121238 A KR1020150121238 A KR 1020150121238A KR 20150121238 A KR20150121238 A KR 20150121238A KR 101566320 B1 KR101566320 B1 KR 101566320B1
- Authority
- KR
- South Korea
- Prior art keywords
- root
- extract
- maca
- leaf
- fermented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 89
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000002537 cosmetic Substances 0.000 title claims abstract description 36
- 244000018716 Impatiens biflora Species 0.000 title claims abstract description 18
- 235000015912 Impatiens biflora Nutrition 0.000 title description 2
- 244000215747 Pachyrhizus erosus Species 0.000 title description 2
- 244000050053 Rosa multiflora Species 0.000 title description 2
- 235000000656 Rosa multiflora Nutrition 0.000 title description 2
- 244000184734 Pyrus japonica Species 0.000 title 1
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 55
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 55
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 55
- 238000000855 fermentation Methods 0.000 claims abstract description 45
- 230000004151 fermentation Effects 0.000 claims abstract description 45
- 235000007173 Abies balsamea Nutrition 0.000 claims abstract description 16
- 239000004857 Balsam Substances 0.000 claims abstract description 16
- 230000036560 skin regeneration Effects 0.000 claims abstract description 15
- 241000223678 Aureobasidium pullulans Species 0.000 claims abstract description 13
- 230000007794 irritation Effects 0.000 claims abstract description 11
- 241000282553 Macaca Species 0.000 claims abstract description 6
- 241001480003 Chaetothyriales Species 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 244000063299 Bacillus subtilis Species 0.000 claims description 10
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 241000233866 Fungi Species 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 230000032683 aging Effects 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims description 3
- 229920001218 Pullulan Polymers 0.000 claims description 3
- 238000010564 aerobic fermentation Methods 0.000 claims description 3
- 235000019423 pullulan Nutrition 0.000 claims description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000008223 sterile water Substances 0.000 claims description 2
- 241000180364 Balsamia Species 0.000 claims 1
- 241000186016 Bifidobacterium bifidum Species 0.000 claims 1
- 241000255789 Bombyx mori Species 0.000 claims 1
- 241000234280 Liliaceae Species 0.000 claims 1
- 235000021420 balsamic vinegar Nutrition 0.000 claims 1
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 claims 1
- 229940018503 zyban Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 239000000463 material Substances 0.000 abstract description 15
- 241000196324 Embryophyta Species 0.000 abstract description 9
- 230000001747 exhibiting effect Effects 0.000 abstract description 3
- 230000000116 mitigating effect Effects 0.000 abstract description 3
- 244000024873 Mentha crispa Species 0.000 abstract description 2
- 235000014749 Mentha crispa Nutrition 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 238000009472 formulation Methods 0.000 description 21
- 239000000126 substance Substances 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 17
- 235000016709 nutrition Nutrition 0.000 description 14
- 108010035532 Collagen Proteins 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 229920001436 collagen Polymers 0.000 description 11
- 239000006210 lotion Substances 0.000 description 11
- 230000003078 antioxidant effect Effects 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 230000004663 cell proliferation Effects 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 241000193388 Bacillus thuringiensis Species 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- 229940097012 bacillus thuringiensis Drugs 0.000 description 7
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 108010002352 Interleukin-1 Proteins 0.000 description 5
- 206010057190 Respiratory tract infections Diseases 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000020688 green tea extract Nutrition 0.000 description 5
- 229940094952 green tea extract Drugs 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- -1 dissolution aids Substances 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 230000036570 collagen biosynthesis Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000554155 Andes Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 244000061508 Eriobotrya japonica Species 0.000 description 2
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000186610 Lactobacillus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 108090000189 Neuropeptides Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- UYLUJGRCKKSWHS-UHFFFAOYSA-N prop-1-en-1-one Chemical compound CC=C=O UYLUJGRCKKSWHS-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- HVTQDSGGHBWVTR-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-phenylmethoxypyrazol-1-yl]-1-morpholin-4-ylethanone Chemical compound C(C1=CC=CC=C1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CCOCC1 HVTQDSGGHBWVTR-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000526061 Balsamorhiza Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 229940124638 COX inhibitor Drugs 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 108010093008 Kinins Proteins 0.000 description 1
- 102000002397 Kinins Human genes 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000282567 Macaca fascicularis Species 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- 102100024304 Protachykinin-1 Human genes 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000005809 anti-tumor immunity Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000000443 biocontrol Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000003152 bradykinin antagonist Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052599 brucite Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 1
- 229940093541 dicetylphosphate Drugs 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000019171 interleukin-1 alpha production Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- RYZCLUQMCYZBJQ-UHFFFAOYSA-H lead(2+);dicarbonate;dihydroxide Chemical compound [OH-].[OH-].[Pb+2].[Pb+2].[Pb+2].[O-]C([O-])=O.[O-]C([O-])=O RYZCLUQMCYZBJQ-UHFFFAOYSA-H 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
구 분 | 혼합 비율 | 수득률(%) |
실시예 2 | 1:2:1:1:1 | 81 |
실시예 3 | 1:1:2:1:1 | 100 |
실시예 4 | 1:1:1:2:1 | 80 |
실시예 5 | 2:1:1:1:1 | 70 |
실시예 6 | 2:2:1:1:1 | 60 |
실시예 7 | 2:3:2:1:1 | 50 |
실시예 8 | 3:1:1:2:1 | 48 |
실시예 9 | 3:2:1:1:1 | 42 |
실시예 10 | 4:1:1:1:1 | 40 |
번호 | 원 료 | 함량(중량%) |
1 | 흑효모 발효 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물(실시예 3) | 1.0 |
2 | 글리세린 | 3.0 |
3 | 부틸렌글리콜 | 2.0 |
4 | 프로필렌글리콜 | 2.0 |
5 | 폴리옥시에칠렌 경화피마자유 | 1.0 |
6 | 에탄올 | 10.0 |
7 | 트리에탄올아민 | 0.1 |
8 | 방부제 | 미량 |
9 | 색소 | 미량 |
10 | 향료 | 미량 |
11 | 정제수 | 잔량 |
번호 | 원 료 | 함량(중량%) |
1 | 흑효모 발효 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물(실시예 3) | 1.0 |
2 | 밀납 | 1.0 |
3 | 폴리솔베이트 60 | 1.5 |
4 | 솔비탄 세스퀴올레이트 | 0.5 |
5 | 유동 파라핀 | 10.0 |
6 | 소르비탄 스테아레이트 | 1.0 |
7 | 친유형 모노스테아린산 글리세린 | 0.5 |
8 | 스테아린산 | 1.5 |
9 | 글리세릴스테아레이트/피이지-400 스테아레이트 | 1.0 |
10 | 프로필렌글리콜 | 3.0 |
11 | 카르복시폴리머 | 0.1 |
12 | 트리에탄올아민 | 0.2 |
13 | 방부제 | 미량 |
14 | 색소 | 미량 |
15 | 향료 | 미량 |
16 | 정제수 | 잔량 |
번호 | 원 료 | 함량(중량%) |
1 | 흑효모 발효 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물(실시예 3) | 1.0 |
2 | 잔탄검 | 0.02 |
3 | 부틸렌글리콜 | 10.0 |
4 | 소이빈포스포리피드 | 10.0 |
5 | 하이드록시에틸셀룰로오즈 | 0.1 |
6 | 소디움히아루로네이트 | 5.0 |
7 | 정제수 | 잔량 |
번호 | 원 료 | 함량(중량%) |
1 | 흑효모 발효 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물(실시예 3) | 1.0 |
2 | 시토 스테롤 | 1.7 |
3 | 폴리에칠렌 글리콜 | 1.5 |
4 | 세라마이드 | 0.7 |
5 | 스테아르산 | 1.2 |
6 | 콜레스테롤 | 1.5 |
7 | 디세틸포스페이트 | 0.4 |
8 | 농글리세린 | 5.0 |
9 | 마카다미아 오일 | 15.0 |
10 | 카르복시비닐폴리머 | 0.2 |
11 | 산탄검 | 0.2 |
12 | 방부제 | 미량 |
13 | 향료 | 미량 |
14 | 정제수 | 잔량 |
농도(%) | 세포 증식률(%) | |||||
대조군 | 0.1 | 0.5 | 1.0 | 2.0 | 5.0 | |
실시예 1 | 100 | 102.9 | 102.0 | 101.5 | 99.9 | 100.2 |
실시예 2 | 100 | 101.6 | 101.8 | 100.9 | 100.4 | 99.6 |
실시예 3 | 100 | 105.8 | 103.9 | 102.1 | 103.7 | 101.0 |
실시예 4 | 100 | 101.7 | 100.4 | 99.7 | 101.0 | 99.6 |
실시예 5 | 100 | 100.9 | 101.5 | 100.8 | 99.9 | 98.9 |
실시예 6 | 100 | 101.7 | 100.4 | 99.7 | 101.0 | 99.6 |
실시예 7 | 100 | 100.9 | 101.5 | 100.8 | 99.9 | 98.9 |
실시예 8 | 100 | 101.6 | 101.0 | 100.8 | 99.4 | 98.6 |
실시예 9 | 100 | 101.2 | 100.7 | 100.5 | 100.8 | 97.8 |
실시예 10 | 100 | 102.9 | 101.4 | 100.1 | 99.5 | 99.8 |
온도 조건 |
안정성 확인 (변색, 변취 및 분리) | |||
제형예 1 | 제형예 2 | 제형예 3 | 제형예 4 | |
실온 | 0 | 0 | 0 | 0 |
4℃ | 0 | 0 | 0 | 0 |
45℃ | 0 | 0 | 0 | 0 |
시료명 | 처리 농도(%) | 항산화효과(%) |
흑효모 발효 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리복합추출물(실시예 3) | 0.01 | 93 |
봉선화, 영실, 마카, 비파나무 잎, 및 얌빈 뿌리 중탕 추출물(비교예1) | 0.01 | 78 |
봉선화, 영실, 마카, 비파나무 잎, 및 얌빈뿌리 효모 발효복합추출물(비교예2) | 0.01 | 75 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈뿌리 락토바실러스 발효 복합추출물(비교예3) | 0.01 | 73 |
녹차 추출물(비교예 4) | 0.01 | 50 |
비타민 E(SIGMA, USA) | 0.01 | 53 |
시료명 | IL-1α생성율(%) |
대조군 | 33.41 ± 1.67 |
SDS만 처리 | 100.00 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 중탕 추출물(비교예 1) | 90.18 ± 4.80 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 발효 추출물(비교예 2) | 82.12 ± 3.41 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 발효 추출물(비교예 3) | 85.23 ± 3.21 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 흑효모 복합발효추출물(실시예 3) | 68.33 ± 3.06 |
Ketopropen | 63.15 ± 4.96 |
시료명 | 콜라겐 생합성 비율(RCB)(%) |
무처리 대조군 | 100 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 중탕추출물 (비교예 1) |
110 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 발효추출물 (비교예 2) |
135 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 발효추출물 (비교예 3) |
131 |
봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 흑효모 복합발효추출물 (실시예 3) |
150 |
Claims (9)
- 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물을 흑효모균(Aureobasidium pullulans)으로 발효시킨 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물을 포함하는 피부진정 및 자극완화용 화장료 조성물.
- 제1항에 있어서, 상기 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물은 물, 탄소수 1~4의 알코올, 부틸렌글리콜, 프로필렌글리콜 및 글리세린으로 이루어지는 군으로부터 선택되는 적어도 하나의 추출용매로 추출된 것임을 특징으로 하는 피부진정 및 자극완화용 화장료 조성물.
- 제1항에 있어서, 상기 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물은 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리를 건조 중량비가 1~5:1~5:1~5:1~5:1~5인 비율로 혼합하여 추출된 것임을 특징으로 하는 피부진정 및 자극완화용 화장료 조성물.
- 제1항에 있어서 상기 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물을 흑효모균(Aureobasidium pullulans)으로 발효시킨 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물은 화장료 전체 중량에 대하여 0.001 ~ 30중량% 포함되는 것임을 특징으로 하는 피부진정 및 자극완화용 화장료 조성물.
- 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물을 흑효모균(Aureobasidium pullulans)으로 발효시킨 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물을 포함하는 피부재생용 화장료조성물.
- 제5항에 있어서, 상기 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물은 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리를 건조 중량비 1:1:2:1:1로 혼합하여 물과 탄소수 1~4의 알코올의 혼합용매에 의하여 추출된 것임을 특징으로 하는 피부재생용 화장료조성물.
- 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리를 건조중량비 1~5:1~5:1~5:1~5:1~5로 혼합하고 용매로 추출하여 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물을 제조하는 단계;
흑효모균(Aureobasidium pullulans)을 배양하여 MEA배지(Malt Extract Medium)에 접종하고 23~28℃ 진탕 배양기에서 16~20시간 동안 배양한 후 계대 배양하고 상기 배양된 균주를 멸균수로 세척하고 초기 균수를 105 ~ 108cfu/㎖로 조절하여 흑효모 스타터를 제조하는 단계;
상기 흑효모 스타터를 총 중량의 3%가 되도록 상기 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합추출물에 접종한 후 24~26℃에서 60~80시간 호기성 발효시키는 단계; 및
발효 완료 후 65~80℃에서 8~15분간 가열하여 실화를 유도하고 발효액을 여과 후 감압농축하는 단계를 포함하는 흑효모균을 이용한 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물의 제조방법. - 제7항에 있어서, 상기 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리를 건조중량비 1:1:2:1:1로 혼합하고 용매로 추출하는 것임을 특징으로 하는 흑효모균을 이용한 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물의 제조방법.
- 제7항에 있어서, 여과 후 저온 숙성 또는 고온 숙성하는 공정을 더욱 포함하는 것을 특징으로 하는 흑효모균을 이용한 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150121238A KR101566320B1 (ko) | 2015-08-27 | 2015-08-27 | 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물을 포함하는 피부 재생, 진정 및 자극완화용 화장료조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150121238A KR101566320B1 (ko) | 2015-08-27 | 2015-08-27 | 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물을 포함하는 피부 재생, 진정 및 자극완화용 화장료조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101566320B1 true KR101566320B1 (ko) | 2015-11-05 |
Family
ID=54600745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150121238A Active KR101566320B1 (ko) | 2015-08-27 | 2015-08-27 | 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물을 포함하는 피부 재생, 진정 및 자극완화용 화장료조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101566320B1 (ko) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101705801B1 (ko) | 2016-06-08 | 2017-02-10 | 주식회사 차밍코스메틱 | 참마 뿌리 추출 발효물, 타이칡 뿌리 추출물, 미네랄 추출물 및 포피라 움빌리칼리스 추출물을 포함하는 화장료 조성물 |
FR3058066A1 (fr) * | 2016-11-03 | 2018-05-04 | Mayor In-Vivo | Composition cosmetique ou pharmaceutique a base de eriobotrya japonica fermente ayant une action anti-age global de prevention de la sarcopenie et du vieillissement de la peau |
CN111012700A (zh) * | 2018-10-09 | 2020-04-17 | 百岳特生物技术(上海)有限公司 | 凉薯发酵物及其用于制备提升基因表现量、以及降低皮肤黑色素含量的组合物的用途 |
JP2020200255A (ja) * | 2019-06-07 | 2020-12-17 | クラシエホームプロダクツ株式会社 | 皮膚化粧料 |
KR20210013501A (ko) | 2019-07-26 | 2021-02-04 | 주식회사 크릴랜드 | 피부 보호효과를 갖는 비파나무 잎 미네랄당 숙성액 및 이의 제조 방법 |
CN112708590A (zh) * | 2019-10-24 | 2021-04-27 | 大江生医股份有限公司 | 促进艾克曼嗜黏蛋白菌生长的组合物及其用途 |
KR20220068350A (ko) | 2020-11-19 | 2022-05-26 | 광주여자대학교 산학협력단 | 비파나무 잎 및 녹차의 복합 식물 추출물을 유효성분으로 하는 자외선-a 차단 및 항산화용 화장료 조성물 |
KR20220087097A (ko) | 2020-12-17 | 2022-06-24 | 주식회사 크릴랜드 | 비파엽 및 가지의 혼합숙성액을 포함하는 화장료 조성물 및 이의 제조방법 |
KR20230037801A (ko) | 2021-09-10 | 2023-03-17 | 광주여자대학교 산학협력단 | 커피나무 잎 분말 추출물을 유효성분으로 함유하는 항산화용 화장료 조성물 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101458887B1 (ko) | 2014-07-09 | 2014-11-12 | 씨앤텍 주식회사 | 히카마, 콜리플라워, 말로우 및 아이슬란드 이끼 천연 복합추출물을 유효성분으로 함유하는 항산화, 보습, 피부 자극 완화 효과를 갖는 피부 개선용 화장료 조성물 |
-
2015
- 2015-08-27 KR KR1020150121238A patent/KR101566320B1/ko active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101458887B1 (ko) | 2014-07-09 | 2014-11-12 | 씨앤텍 주식회사 | 히카마, 콜리플라워, 말로우 및 아이슬란드 이끼 천연 복합추출물을 유효성분으로 함유하는 항산화, 보습, 피부 자극 완화 효과를 갖는 피부 개선용 화장료 조성물 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101705801B1 (ko) | 2016-06-08 | 2017-02-10 | 주식회사 차밍코스메틱 | 참마 뿌리 추출 발효물, 타이칡 뿌리 추출물, 미네랄 추출물 및 포피라 움빌리칼리스 추출물을 포함하는 화장료 조성물 |
FR3058066A1 (fr) * | 2016-11-03 | 2018-05-04 | Mayor In-Vivo | Composition cosmetique ou pharmaceutique a base de eriobotrya japonica fermente ayant une action anti-age global de prevention de la sarcopenie et du vieillissement de la peau |
CN111012700A (zh) * | 2018-10-09 | 2020-04-17 | 百岳特生物技术(上海)有限公司 | 凉薯发酵物及其用于制备提升基因表现量、以及降低皮肤黑色素含量的组合物的用途 |
CN111012700B (zh) * | 2018-10-09 | 2023-02-17 | 百岳特生物技术(上海)有限公司 | 凉薯发酵物及其用于制备提升基因表现量、以及降低皮肤黑色素含量的组合物的用途 |
JP2020200255A (ja) * | 2019-06-07 | 2020-12-17 | クラシエホームプロダクツ株式会社 | 皮膚化粧料 |
KR20210013501A (ko) | 2019-07-26 | 2021-02-04 | 주식회사 크릴랜드 | 피부 보호효과를 갖는 비파나무 잎 미네랄당 숙성액 및 이의 제조 방법 |
CN112708590A (zh) * | 2019-10-24 | 2021-04-27 | 大江生医股份有限公司 | 促进艾克曼嗜黏蛋白菌生长的组合物及其用途 |
CN112708590B (zh) * | 2019-10-24 | 2024-05-10 | 大江生医股份有限公司 | 促进艾克曼嗜黏蛋白菌生长的组合物及其用途 |
KR20220068350A (ko) | 2020-11-19 | 2022-05-26 | 광주여자대학교 산학협력단 | 비파나무 잎 및 녹차의 복합 식물 추출물을 유효성분으로 하는 자외선-a 차단 및 항산화용 화장료 조성물 |
KR20220087097A (ko) | 2020-12-17 | 2022-06-24 | 주식회사 크릴랜드 | 비파엽 및 가지의 혼합숙성액을 포함하는 화장료 조성물 및 이의 제조방법 |
KR20230037801A (ko) | 2021-09-10 | 2023-03-17 | 광주여자대학교 산학협력단 | 커피나무 잎 분말 추출물을 유효성분으로 함유하는 항산화용 화장료 조성물 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101566320B1 (ko) | 봉선화, 영실, 마카, 비파나무 잎 및 얌빈 뿌리 복합발효추출물을 포함하는 피부 재생, 진정 및 자극완화용 화장료조성물 | |
KR101723526B1 (ko) | 동백꽃, 벚꽃, 쟈스민꽃, 캐모마일꽃 및 연꽃 혼합추출물을 함유하는 화장료 조성물 | |
JPH0717847A (ja) | 皮膚外用剤 | |
KR101319990B1 (ko) | 천문동 및 마카 복합발효추출물을 포함하는 피부 재생, 진정 및 자극완화용 화장료조성물 | |
KR101452770B1 (ko) | 유산균 발효액을 함유하는 항산화, 미백 및 주름개선 효과를 갖는 화장료 조성물 | |
KR102354412B1 (ko) | 혼합 꽃 추출물의 유산균 발효물을 유효성분으로 함유하는 화장료 조성물 | |
KR20110076043A (ko) | 청미래덩굴 추출물을 유효성분으로 함유하는 화장료 조성물 | |
CN113631227B (zh) | 抗老化剂、抗氧化剂、抗炎剂、及美白剂、以及化妆品 | |
CN115137673A (zh) | 一种发酵类化妆品组合物及其制备方法和应用 | |
KR101914344B1 (ko) | 발효보리, 발효배즙, 발효콩 및 발효석류 추출물을 유효성분으로 하는 피부 보습력과 주름 개선 효능을 가지는 화장료 조성물 | |
KR20140110376A (ko) | 꽃초 추출물을 함유하는 피부 외용제 조성물 | |
KR102113645B1 (ko) | 미세침 분말 및 천연 추출물을 유효성분으로 포함하는 탈모 방지 및 모발 성장 촉진용 화장료 조성물 | |
KR20190049067A (ko) | 커피 실버스킨 및 커피박 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR20210155987A (ko) | 락토바실러스 브레비스 균주로 발효한 해조류 복합 발효 추출물을 유효성분으로 포함하는 피부 탄력 또는 피부 주름 개선, 항산화 및 피부 보습용 조성물 | |
KR20190071883A (ko) | 빌베리열매의 미생물 발효를 통한 저분자 펩타이드를 함유하는 피부 보호 및 주름 개선용 화장료 조성물 | |
KR102303400B1 (ko) | 제주 용암해수, 제주 보리누룩 및 천연식물을 이용한 발효물 제조방법 및 이를 포함하는 화장품 조성물 및 그 제조방법 | |
KR100981344B1 (ko) | 피부 노화 방지용 화장료 조성물 | |
KR20140054951A (ko) | 발효 한방 혼합 추출물이 함유된 미백 화장료 조성물 | |
KR101326102B1 (ko) | 홍국 발효 추출물을 포함하는 화장료 조성물 | |
KR102364428B1 (ko) | 항산화 활성이 우수한 8종 곡물 발효추출물을 함유하는 피부 개선용 화장료 조성물 | |
KR102154139B1 (ko) | 고로쇠나무 수액의 발효액, 카카오닙스 추출물 및 석류피 추출물을 포함하는 조성물 | |
KR20190067287A (ko) | 무궁화의 꽃, 뿌리, 캘러스 및 씨의 혼합 추출물을 유효성분으로 함유하는 항노화 및 항알러지용 화장료 조성물 및 그 제조방법 | |
KR102214621B1 (ko) | 흑다시마를 유효성분으로 포함하는 식품 조성물 | |
KR102029585B1 (ko) | 3종 발효 혼합 추출물을 함유하는 보습, 항염 및 항알러지 기능성 화장료 조성물 및 그 제조방법 | |
KR20120119520A (ko) | 대나무수액의 균발효 추출물을 함유하는 피부외용제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20150827 |
|
PA0201 | Request for examination | ||
A302 | Request for accelerated examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20150910 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20150827 Patent event code: PA03021R01I Comment text: Patent Application |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20151026 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20151030 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20151030 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20181030 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20181030 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190813 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20190813 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20210809 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20220822 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20230816 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20241203 Start annual number: 10 End annual number: 10 |